慢性肺同种异体移植物功能障碍的临床试验
总计6266个结果
-
AstraZenecaAmgen完全的
-
Tufts Medical CenterVirginia Commonwealth University主动,不招人
-
Weill Medical College of Cornell UniversityNational Heart, Lung, and Blood Institute (NHLBI); University of Michigan; Duke University; Wake... 和其他合作者完全的
-
Imperial College LondonRoyal Brompton & Harefield NHS Foundation Trust撤销
-
University of AarhusResearch Unit for General Practice, Aarhus University; Ringkoebing-Skjern Municipality, Denmark... 和其他合作者完全的慢性阻塞性肺病 | Implementation of a Chronic Disease Management Programme
-
Johns Hopkins UniversityNational Institute on Aging (NIA); Reading Hospital Family Health Care Center完全的
-
University College, LondonSouth London and Maudsley NHS Foundation Trust主动,不招人
-
National Heart, Lung, and Blood Institute (NHLBI)完全的肺部疾病,阻塞性 | 慢性阻塞性肺疾病 | 哮喘
-
McGill UniversityNational Heart, Lung, and Blood Institute (NHLBI)完全的肺部疾病 | 肺部疾病,阻塞性 | 慢性阻塞性肺疾病
-
Lithuanian University of Health Sciences招聘中
-
Convexity Scientific IncCOPD Foundation完全的
-
Hospital de Clinicas de Porto AlegreUniversidade Federal do Rio de Janeiro; Pontifícia Universidade Católica do Paraná招聘中
-
GlaxoSmithKline主动,不招人
-
GlaxoSmithKline完全的
-
Chiesi Farmaceutici S.p.A.完全的中度至重度慢性阻塞性肺疾病 (COPD)保加利亚, 德国, 匈牙利, 波兰, 俄罗斯联邦, 英国
-
AstraZenecaParexel完全的
-
AstraZeneca完全的
-
Newcastle-upon-Tyne Hospitals NHS TrustAstraZeneca; Newcastle University完全的
-
Bahçeşehir UniversityTugtepe Pediatric Urology Clinic完全的
-
National University of Malaysia尚未招聘
-
Maria Joyera Rodríguez尚未招聘
-
Georg Nilius, Prof DR medHeinen und Löwenstein GmbH & Co. KG招聘中
-
Milton S. Hershey Medical CenterNational Heart, Lung, and Blood Institute (NHLBI)招聘中
-
Respiratory Effectiveness GroupBoehringer Ingelheim完全的
-
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.主动,不招人